BNP Paribas Financial Markets
OXFD

BNP Paribas Financial Markets’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

BNP Paribas Financial Markets’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21
Closed -$194 – 4426
2020
Q1 		$194 Hold
21
– – ﹤0.01% 4184
2019
Q4 		$349 Sell
21
-1,530
-99% -$24.8K ﹤0.01% 4275
2019
Q3 		$25.8K Sell
1,551
-1,346
-46% -$18.6K ﹤0.01% 3833
2019
Q2 		$39.9K Sell
2,897
-2,511
-46% -$38.4K ﹤0.01% 3564
2019
Q1 		$93.2K Buy
5,408
+5,399
+59,989% +$85.4K ﹤0.01% 3164
2018
Q4 		$115 Sell
9
-743
-99% -$11.3K ﹤0.01% 4166
2018
Q3 		$12.2K Sell
752
-45
-6% -$643 ﹤0.01% 3642
2018
Q2 		$10.3K Sell
797
-4,841
-86% -$65.4K ﹤0.01% 3770
2018
Q1 		$70.2K Sell
5,638
-71
-1% -$864 ﹤0.01% 3374
2017
Q4 		$79.8K Buy
5,709
+3,483
+156% +$51K ﹤0.01% 3428
2017
Q3 		$37.4K Sell
2,226
-155
-7% -$2.52K ﹤0.01% 3297
2017
Q2 		$40K Buy
2,381
+2,309
+3,207% +$34.5K ﹤0.01% 3310
2017
Q1 		$1.11K Sell
72
-1,105
-94% -$15.8K ﹤0.01% 3674
2016
Q4 		$17.6K Sell
1,177
-466
-28% -$6.54K ﹤0.01% 3239
2016
Q3 		$20.6K Buy
1,643
+779
+90% +$7.82K ﹤0.01% 2876
2016
Q2 		$7.78K Buy
+864
New +$8.46K ﹤0.01% 3041
2016
Q1 		– Sell
-3,834
Closed -$44.1K – 3262
2015
Q4 		$44.1K Sell
3,834
-161
-4% -$1.99K ﹤0.01% 2897
2015
Q3 		$53.9K Buy
3,995
+2,319
+138% +$31.4K ﹤0.01% 2802
2015
Q2 		$23.2K Buy
1,676
+1,279
+322% +$17.3K ﹤0.01% 2949
2015
Q1 		$5.59K Buy
+397
New +$5.4K ﹤0.01% 3087
2014
Q4 		– Sell
-1,147
Closed -$17.5K – 3511
2014
Q3 		$17.5K Buy
+1,147
New +$17.6K ﹤0.01% 3258
2014
Q1 		– Sell
-76
Closed -$1.47K – 3945
2013
Q4 		$1.47K Buy
+76
New +$1.34K ﹤0.01% 3770

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BNP Paribas Financial Markets's OXFD Position: Q2 2020 in Review

BNP Paribas Financial Markets sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2020, closing a stake of 21 shares — an estimated $194 sold.

BNP Paribas Financial Markets first reported a position in OXFD in Q4 2013 and held it in 22 quarters. The position peaked at $93.2K in Q1 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q2 2020.

  • BNP Paribas Financial Markets reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 21 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2020, an estimated $194.
  • BNP Paribas Financial Markets first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 22 quarters.
  • BNP Paribas Financial Markets's Oxford Immunotec Global PLC Ordinary Shares position peaked at $93.2K in Q1 2019.
  • 65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.